2186.HK · LUYE PHARMA
Hong Kong · RS rating 14 · As of 2026-10-14
| Price | 1.70 HKD |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 41 / 16 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 13 / 21 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.6% |
| Market cap (USD) | $880.5M |